SecSonar.com

Zhengye Biotechnology Holding Limited (ZYBT)

Zhengye Biotechnology Holding Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Zhengye Biotechnology Holding Limited (ZYBT) is a Drug Manufacturers - Specialty & Generic company based in CN with a market capitalization of $39.4M. Revenue declined 37.6% year-over-year and the company generated $103.8K in free cash flow. This page tracks ZYBT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 278 employees · IPO Jan 7, 2025

Valuation

Valuation & price

$0.95 · as of May 17, 2026 · -92.5% vs 52w high

4.0

P/E ratio

Latest-FY diluted EPS

0.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.04$5.34$0.65Jul 25Dec 25Jul 26Jul 7, 25$5.54Jul 9, 25$6.09Jul 11, 25$5.89Jul 15, 25$5.56Jul 17, 25$5.87Jul 21, 25$5.69Jul 23, 25$5.78Jul 25, 25$5.55Jul 29, 25$5.50Jul 31, 25$5.53Aug 4, 25$5.76Aug 6, 25$5.45Aug 11, 25$5.38Aug 13, 25$8.40Aug 15, 25$7.51Aug 19, 25$7.60Aug 21, 25$6.70Aug 25, 25$8.00Aug 27, 25$8.76Aug 29, 25$9.36Sep 3, 25$9.75Sep 5, 25$8.19Sep 9, 25$9.82Sep 11, 25$9.21Sep 16, 25$10.04Sep 18, 25$9.47Sep 22, 25$8.73Sep 24, 25$4.97Sep 26, 25$1.84Sep 30, 25$2.62Oct 2, 25$2.55Oct 6, 25$2.88Oct 8, 25$3.08Oct 10, 25$2.74Oct 14, 25$2.89Oct 16, 25$2.56Oct 21, 25$2.51Oct 23, 25$2.52Oct 27, 25$2.32Oct 29, 25$2.46Oct 31, 25$2.46Nov 4, 25$2.22Nov 6, 25$2.12Nov 10, 25$2.07Nov 12, 25$2.16Nov 14, 25$2.20Nov 18, 25$2.13Nov 20, 25$2.06Nov 25, 25$2.35Nov 28, 25$2.09Dec 2, 25$2.16Dec 4, 25$2.20Dec 8, 25$2.15Dec 10, 25$2.02Dec 12, 25$2.01Dec 16, 25$1.86Dec 18, 25$1.84Dec 22, 25$1.80Dec 24, 25$1.68Dec 29, 25$1.20Jan 2, 26$1.13Jan 6, 26$1.14Jan 8, 26$1.14Jan 12, 26$1.17Jan 14, 26$1.12Jan 16, 26$1.10Jan 21, 26$1.09Jan 23, 26$1.04Jan 27, 26$1.02Jan 29, 26$0.94Feb 2, 26$0.94Feb 4, 26$0.84Feb 9, 26$1.05Feb 11, 26$1.02Feb 13, 26$0.96Feb 18, 26$0.97Feb 20, 26$0.88Feb 24, 26$0.81Feb 26, 26$0.81Mar 2, 26$0.77Mar 4, 26$0.81Mar 6, 26$0.75Mar 10, 26$0.78Mar 12, 26$0.77Mar 17, 26$0.72Mar 19, 26$1.09Mar 23, 26$1.00Mar 25, 26$0.88Mar 27, 26$0.84Mar 31, 26$0.93Apr 2, 26$0.88Apr 7, 26$0.92Apr 9, 26$0.99Apr 13, 26$1.20Apr 15, 26$1.11Apr 17, 26$0.99Apr 22, 26$0.92Apr 24, 26$0.92Apr 28, 26$0.92Apr 30, 26$0.92May 4, 26$0.99May 6, 26$0.98May 8, 26$0.95May 12, 26$1.01May 14, 26$0.95May 18, 26$0.92May 20, 26$0.89May 22, 26$0.87May 28, 26$0.81Jun 1, 26$0.85Jun 3, 26$0.80Jun 5, 26$0.83Jun 9, 26$0.89Jun 11, 26$0.90Jun 15, 26$0.81Jun 17, 26$0.78Jun 22, 26$0.72Jun 24, 26$0.77Jun 26, 26$0.71Jul 2, 26$0.65
$0.6552-week range$12.66
Loading valuation history…

Fundamentals

Key fundamentals

$39.4M

Market cap

-37.6%

Revenue growth (YoY)

20.5%

Gross margin

$103.8K

Free cash flow (USD)

$23.2M

Net debt

3.3%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2021 → 2025

FY 2021$214.1MFY 2022$260.3MFY 2023$211.7MFY 2024$186.4MFY 2025$116.4M
$214.1M$116.4M

Free cash flow by year

2021 → 2025

FY 2021$5.4MFY 2022$-10.0MFY 2023$36.6MFY 2024$13.3MFY 2025$703.0K
$5.4M$703K

Gross margin by year

2021 → 2025

FY 202158.6%FY 202259.0%FY 202361.4%FY 202449.0%FY 202520.5%
58.6%20.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 20-F filed Apr 28, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingRegulatory UpdateJun 4, 2026Filing
  • Annual report20-F FiledApr 28, 2026Filing

Questions

Frequently asked questions

What is Zhengye Biotechnology Holding Limited's market cap?

Zhengye Biotechnology Holding Limited (ZYBT) has a market capitalization of $39.4M.

What is ZYBT's P/E ratio?

ZYBT trades at a price-to-earnings ratio of 4.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ZYBT's price-to-book (P/B) ratio?

ZYBT trades at 0.16 times book value per share.

Are insiders buying ZYBT stock?

SEC Form 4 filings show no open-market insider buys at Zhengye Biotechnology Holding Limited in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

IXHL

Incannex Healthcare Limited

$39.6M

SCYX

SCYNEXIS, Inc.

$37.7M

RMTI

Rockwell Medical, Inc.

$29.3M

TXMD

TherapeuticsMD, Inc.

$24.2M

OPTH

Optimi Health Corp.

$19.6M

AYTU

Aytu BioPharma, Inc.

$17.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.